Melissa Otte, PA
Physician Assistant · Concord, NHNPI 1447595475
Payments from drug & device makers
Across 36 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$350
- Boehringer Ingelheim$77
- Lilly USA, LLC$74
- Sanofi-aventis U.S. LLC$70
- Madrigal Pharmaceuticals$59
- Abbott$49
- plus $102 from 3 others
What the payments were for
- Food & beverage$782100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $350 |
| Boehringer Ingelheim | 4 | $77 |
| Lilly USA, LLC | 4 | $74 |
| Sanofi-aventis U.S. LLC | 2 | $70 |
| Madrigal Pharmaceuticals | 3 | $59 |
| Abbott | 3 | $49 |
| Amgen | 2 | $45 |
| Radius Health, Inc. | 1 | $35 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
How this compares
$782 in reported general payments places this provider in the 85th percentile of 782 physician assistant providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 118 | $179,227 |
| TrulicityDulaglutide | 59 | $60,362 |
| MounjaroTirzepatide | 53 | $57,810 |
| JardianceEmpagliflozin | 38 | $50,710 |
| FarxigaDapagliflozin Propanediol | 23 | $25,242 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $23,870 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 25 | $22,370 |
| Tresiba Flextouch U-100Insulin Degludec | 41 | $20,206 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $14,226 |
| Humalog Kwikpen U-100Insulin Lispro | 23 | $11,171 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $11,068 |
| Novolog FlexpenInsulin Aspart | 27 | $7,075 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $6,345 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 65 | $5,521 |
| SynthroidLevothyroxine Sodium | 75 | $3,821 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $74 | $118,171112 claims |
| Boehringer IngelheimJardiance | $77 | $50,71038 claims |
| AstraZenecaFarxiga | $350 | $25,24223 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $70 | $14,22611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 782 physician assistant providers in New Hampshire.
Other physician assistant in Concord
- Lindsay OverkoConcord$29K
- Zoe NikitasConcord$6K
- Alicia SloanConcord$4K
- Garrick JohnsonConcord$4K
- Sheli TinkelmanConcord$3K
- Bernard MacgregorConcord$3K
- Sara CarrierConcord$2K
- Katelyn WatsonConcord$2K
- David MorinLebanon$121K
- Joseph ZucchiSalem$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.